(19)
(11) EP 3 952 998 A1

(12)

(43) Date of publication:
16.02.2022 Bulletin 2022/07

(21) Application number: 20721371.1

(22) Date of filing: 08.04.2020
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
C07D 401/04(2006.01)
C07D 491/107(2006.01)
C07D 239/22(2006.01)
C07D 403/04(2006.01)
A61K 31/506(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 239/22; C07D 491/107; C07D 403/04; C07D 401/04; A61P 35/00
(86) International application number:
PCT/US2020/027309
(87) International publication number:
WO 2020/210384 (15.10.2020 Gazette 2020/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.04.2019 EP 19167897
29.07.2019 US 201962879816 P
26.03.2020 US 202063000257 P

(71) Applicant: Merck Patent GmbH
64293 Darmstadt (DE)

(72) Inventors:
  • JORAND-LEBRUN, Catherine
    Arlington, Massachusetts 02474 (US)
  • BOIVIN, Roch
    Chelmsford, Massachusetts 01863 (US)
  • JOHNSON, Theresa
    Salem, Massachusetts 01970 (US)
  • WANG, Yanping
    Billerica, Massachusetts 01821 (US)
  • XIAO, Yufang
    Lexington, Massachusetts 02421 (US)
  • CHEN, Xiaoling
    Chestnut Hill, Massachusetts 02467 (US)
  • LINDE, Nina
    60325 Frankfurt am Main (DE)
  • MUSCH, Doreen
    64354 Reinheim (DE)
  • KUMAR, Deepak
    Canton, Massachusetts 02021 (US)

   


(54) PYRIMIDINONE DERIVATIVES AS SHP2 ANTAGONISTS